Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Adicet Bio, Inc. (TORC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/28/2020 |
8-K
| Quarterly results |
| 06/23/2020 |
8-K
| Investor presentation |
| 06/02/2020 |
8-K
| Investor presentation |
| 04/29/2020 |
8-K
| Investor presentation|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : April 28, 2020 resTORbio, Inc. Delaware 001-38359 81-3305277 500 Boylston Street, 13th Floor Boston, MA 02116 Registrant's telephone number, including area code: 315-5528 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☒ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commenc...",
"Agreement and Plan of Merger, by and among resTORbio, Inc., Adicet Bio, Inc. and Project Oasis Merger Sub, Inc.",
"resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology",
"Presentation for investor conference call held by resTORbio, Inc. and Adicet Bio, Inc. on April 29, 2020" |
|
| 03/18/2019 |
8-K
| Investor presentation |
| 01/07/2019 |
8-K
| Investor presentation |
| 10/16/2018 |
8-K
| Quarterly results |
| 07/30/2018 |
8-K
| Investor presentation |
|
|